Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19

Mostrar otras versiones (1)

The novel SARS-CoV-2 virus emerged in December 2019 and has few effective treatments. We applied a computational drug repositioning pipeline to SARS-CoV-2 differential gene expression signatures derived from publicly available data. We utilized three independent published studies to acquire or gener...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Brian L., Andreoletti, Gaia, Oskotsky, Tomiko, Vallejo-Gracia, Albert, Rosales, Romel, Yu, Katharine, Kosti, Idit, Leon, Kristoffer E., Bunis, Daniel G., Li, Christine, Kumar, G. Renuka, White, Kris M., García-Sastre, Adolfo, Ott, Melanie, Sirota, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020993/
https://www.ncbi.nlm.nih.gov/pubmed/33821262
http://dx.doi.org/10.21203/rs.3.rs-333578/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020993/
https://www.ncbi.nlm.nih.gov/pubmed/33821262
http://dx.doi.org/10.21203/rs.3.rs-333578/v1

Ejemplares similares